Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.36 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.35 |
| ▸ | ANPEP | P15144 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10378225 | 0.87 | HSD17B10 (0.46) | MAOAMAOBHSD17B10CYP1A2KDM4E | |
| SCHEMBL30779751 | 0.87 | HSD17B10 (0.46) | MAOAMAOBHSD17B10CYP1A2KDM4E | |
| SCHEMBL13777196 | 0.82 | MAOA (0.73) | MAOAMAOBCYP1A2KDM4EHPGD | |
| SCHEMBL28394024 | 0.82 | CYP2A6 (0.39) | MAOAMAOBHSD17B10CYP1A2KDM4E | |
| SCHEMBL28401274 | 0.82 | MAOA (0.47) | MAOAMAOBCYP1A2CYP2C9HPGD | |
| SCHEMBL28888914 | 0.81 | CYP1A2 (0.38) | MAOAMAOBHSD17B10CYP1A2KDM4E | |
| SCHEMBL28405398 | 0.81 | NFKB1 (0.40) | MAOAMAOBHSD17B10CYP1A2KDM4E | |
| SCHEMBL10378227 | 0.81 | KDM4E (0.54) | HSD17B10CYP1A2KDM4EGLACYP2C9 | |
| SCHEMBL5657956 | 0.79 | CYP19A1 (0.47) | MAOAMAOBHSD17B10CYP1A2KDM4E | |
| SCHEMBL4015217 | 0.79 | AKR1B1 (0.37) | MAOAMAOBHSD17B10CYP1A2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3397718-A1 | FLUORESCENT PARTICULATE MATERIAL | L'Oréal (FR) | 2018-11-07 | — | — | EP | claimed |
| WO-2017114877-A1 | FLUORESCENT PARTICULATE MATERIAL | L'OREAL (FR) | 2017-07-06 | — | — | WO | claimed |
| US-9040307-B2 | Fluorescent pH detector system and related methods | BLOOD CELL STORAGE, INC. (US) | 2015-05-26 | — | — | US | claimed |
| EP-1781675-B1 | PHOSPHONATE FLUORESCENT DYES AND CONJUGATES | EPOCH BIOSCIENCES INC (US) | 2014-03-26 | — | — | EP | claimed |
| US-20120322161-A1 | FLUORESCENT pH DETECTOR SYSTEM AND RELATED METHODS | BLOOD CELL STORAGE, INC. (US) | 2012-12-20 | — | — | US | claimed |
| JP-2012500860-A | — | — | 2012-01-12 | — | — | JP | claimed |
| US-7671218-B2 | Phosphonate fluorescent dyes and conjugates | Elitech Holdings B.V. (NL) | 2010-03-02 | — | — | US | claimed |
| WO-2010021512-A2 | SILICA-BASED FLUORESCENT NANOPARTICLES | SNU R&DB FOUNDATION (KR) | 2010-02-25 | — | — | WO | claimed |
| US-20100047859-A1 | SILICA-BASED FLUORESCENT NANOPARTICLES | SNU R&DB FOUNDATION (KR) | 2010-02-25 | — | — | US | claimed |
| EP-2049601-B1 | NOVEL POLYHEDRAL OLIGOMERIC SILSESQUIOXANE (POSS) BASED FLUORESCENT COLORANTS | BASF SE (DE) | 2009-12-09 | — | — | EP | claimed |
| US-20050277144-A1 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-12-15 | — | — | US | claimed |
| US-20050176066-A1 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-08-11 | — | — | US | claimed |
| US-20050171340-A1 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES, INC. (US) | 2005-08-04 | — | — | US | claimed |
| US-20050159606-A1 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-07-21 | — | — | US | claimed |
| WO-2005040357-A2 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES, INC. (US) | 2005-05-06 | — | — | WO | claimed |
| EP-1466176-A2 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | Epoch Biosciences, Inc. (US) | 2004-10-13 | — | — | EP | claimed |
| US-20030152518-A1 | Detection by increased uptake of fluorophore glucose or deoxyglucose conjugates in cancerous and pre-cancerous cells relative to normal cells. | THRESHOLD PHARMACEUTICALS, INC. | 2003-08-14 | — | — | US | claimed |
| WO-2003059149-A2 | METHODS FOR CANCER IMAGING | THRESHOLD PHARMACEUTICALS, INC. (US) | 2003-07-24 | — | — | WO | claimed |
| WO-2003023357-A2 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES, INC. (US) | 2003-03-20 | — | — | WO | claimed |
| US-4945171-A | FLUORESCENT DYES | MOLECULAR PROBES, INC. (US) | 1990-07-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030152518-A1 | Detection by increased uptake of fluorophore glucose or deoxyglucose conjugates in cancerous and pre-cancerous cells relative to normal cells. | SLC2A1, SLC2A4, SLC2A8 | MAOA 3763/4885MAOB 3603/4885HSD17B10 2478/4885 |
| US-20050176066-A1 | Compounds and methods for fluorescent labeling | HLCS, GLB1, TUBB | MAOA 1107/4885MAOB 313/4885HSD17B10 2560/4885 |
| US-20050171340-A1 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | HLCS, GLB1, TUBB | MAOA 1107/4885MAOB 313/4885HSD17B10 2560/4885 |
| US-20050277144-A1 | Compounds and methods for fluorescent labeling | HLCS, GLB1, TUBB | MAOA 1107/4885MAOB 313/4885HSD17B10 2560/4885 |
| US-20100047859-A1 | SILICA-BASED FLUORESCENT NANOPARTICLES | NOXO1, NOX3, SOS1 | MAOA 3726/4885MAOB 4043/4885HSD17B10 2638/4885 |
| US-20050159606-A1 | Compounds and methods for fluorescent labeling | TFEB, HLCS, PFAS | MAOA 863/4885MAOB 211/4885HSD17B10 3826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.